MAKO Surgical (MAKO) Higher as RIO Robotic Arm Now Commercially Available
Tweet
Share
E-mailGet Alerts MAKO Hot Sheet
Join SI Premium – FREE
MAKO Surgical Corp. (Nasdaq: MAKO) is higher Monday following a release that MAKO's RIO Robotic Arm Interactive Orthopedic System is commercially available for use in total hip replacement procedures, called MAKOplasty Total Hip Arthroplasty.
The stock is up over 6 percent on the session, making it one of the stronger moves on a notably down market day.
The stock is up over 6 percent on the session, making it one of the stronger moves on a notably down market day.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Ionis Pharma's therapy to treat rare genetic disorder
- Alumis SLE trial fails primary endpoints; subgroup data guides Phase 3
- Exclusive: PayPal cuts 220 jobs in India, 160 in Ireland
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
